Celltrion Pharm, Inc. (KOSDAQ:068760)

Celltrion Pharm Revenue

Celltrion Pharm had revenue of 85.55B KRW in the quarter ending March 31, 2021, with 92.73% growth. This brings the company's total for the last twelve months to 274.73B, up 53.21% year-over-year. In the year 2020, Celltrion Pharm had annual revenue of 233.57B with 34.61% growth. That makes Celltrion Pharm the 17,293rd largest company in the world by revenue and 873rd in South Korea.

• Revenue (ttm): 274.73B
• Revenue Growth: +53.21%
• P/S Ratio: 5.90
• Revenue / Employee: 837.59M
• Employees: 328
• Market Cap: 1.62T

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 231.98B 99.3%
• Republic of The Philippines 595.89M 0.3%
• Kazakhstan 566.66M 0.2%
• Other 284.99M 0.1%
• Vietnam 138.91M 0.1%

Fiscal year ended Dec 31, 2020

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2020	233.57B	60.06B	34.61%
Dec 31, 2019	173.51B	26.63B	18.13%
Dec 31, 2018	146.88B	11.02B	8.11%
Dec 31, 2017	135.86B	31.05B	29.62%
Dec 31, 2016	104.81B	30.08B	40.25%

Data Source: S&P Global Market Intelligence Last updated: May 14, 2021

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error